NCT01040000 2017-08-04QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerPrecision Biologics, IncPhase 1/2 Completed94 enrolled